David H. Mack - Jun 28, 2021 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
President and CEO, Director
Signature
/s/ David H. Mack
Stock symbol
PMVP
Transactions as of
Jun 28, 2021
Transactions value $
-$7,140
Form type
4
Date filed
6/29/2021, 06:09 PM
Previous filing
Jun 4, 2021
Next filing
Jul 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Options Exercise $108 +204 +1.64% $0.53* 12.7K Jun 28, 2021 Direct
transaction PMVP Common Stock Sale -$7.25K -204 -1.61% $35.53 12.5K Jun 28, 2021 Direct F1
holding PMVP Common Stock 228K Jun 28, 2021 See footnote F2
holding PMVP Common Stock 57K Jun 28, 2021 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Stock Option (right to buy) Options Exercise $0 -204 -0.04% $0.00 475K Jun 28, 2021 Common Stock 204 $0.53 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020.
F2 The shares are held of record by The Mack-Mulligan Revocable Trust, for which the Reporting Person serves as co-trustee.
F3 The shares are held of record by the Mack/Mulligan 2020 Irrevocable Descendants' Trust, for which the Reporting Person serves as co-trustee.
F4 The shares subject to the option are fully vested and immediately exercisable.